Japan, Oct. 21 -- NOVARTIS AG has got intellectual property rights for 'FUSION PROTEIN FOR TREATMENT.' Other related details are as follows:
Application Number: JP,2025-069310
Category (FI): A61K31/198,A61K31/337,A61K31/365,A61K31/42,A61K31/436,A61K31/513,A61K31/519,A61K31/52,A61K31/58,A61K31/635,A61K31/65,A61K31/704,A61K31/706,A61K38/16,A61K38/38,A61K39/395@N,A61K45/00,A61K47/64,A61P1/16,A61P11/00,A61P13/12,A61P17/02,A61P29/00,A61P31/04,A61P37/02,A61P37/06,A61P43/00,121,A61P9/00,A61P9/10,C07D213/76,C07D239/553@A,C07D261/18,C07D305/14,C07D307/88,C07D473/38,C07D475/08,C07D498/18,C07H15/04@B,C07H15/252,C07J71/00,C07K14/765,C07K16/00,C07K19/00,C12N1/15,C12N1/19,C12N1/21,C12N15/14,C12N15/62@Z,C12N15/63@Z,C12N5/10
Stage: Grant (IP right grant...